Akèy › Lupus › Kansas › Kansas City
Etid klinik pou Lupus nan Kansas City, KS
4 etid pou Lupus ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Ap rekriteFaz 3
- Sl0044 50074, Kansas City
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- University of Kansas Cancer Center, Kansas City
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- University of Kansas Medical Center, Kansas City
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Ap rekriteFaz 1/2
- University of Kansas Medical Center, Kansas City
Etid Lupus nan lòt vil
- New York City, NY18 etid
- Houston, TX13 etid
- Durham, NC12 etid
- Washington, DC10 etid
- Miami, FL10 etid
- Tampa, FL9 etid
- Philadelphia, PA9 etid
- Clearwater, FL8 etid
- Santa Monica, CA8 etid
- Oklahoma City, OK8 etid
- Boston, MA8 etid
- Los Angeles, CA8 etid
Lòt etid nan Kansas City
- Maladi kadyovaskilè14 etid
- Maladi poumon entèstisyèl13 etid
- Ensifizyans kadyak13 etid
- Obèsite13 etid
- Fibroz sistik13 etid
- Kansè vejik12 etid
- Kansè pwostat12 etid
- Kansè nan tete12 etid
- Kansè Poumon ki pa ti selil11 etid
- Leksemi mieloïd egi11 etid
- Kansè poumon11 etid
- BPCO9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.